The Supervisory Board currently consists of six members with very specific expertise in FMO’s focus areas.They are appointed by the General Meeting of Shareholders upon nomination of the Supervisory Board. The Works’ Council recommends the nomination of one third of the members.
Supervisory Board Members
Dirk Jan van den Berg (1953), chairman
Dirk Jan van den Berg joined the Supervisory Board in 2016. He is the Chair of the Association of Health Insurance Companies in The Netherlands (Zorgverzekeraars Nederland), Chair of the Supervisory Board of the Dutch Research Council (NWO), Member of the AFKL Board and Chair of the StasQ BV (RadarRadar) Board.
Dirk Jan van den Berg was Chair of the Executive Board of Sanquin Blood Supply (2015-2020) and before that he was the President of Delft University of Technology (2008-2015). He served as the Dutch Ambassador to China and Mongolia (2005-2008), as The Netherlands Permanent Representative to the United Nations (2001-2005) in New York and has been the Secretary-General of the ministry during 1992-2001. Between 1980 and 1992 he held several positions at the Ministry of Economic Affairs, lastly as Deputy Director General for Industry. Dirk Jan van den Berg is trained as an econometrist and is an alumnus of the Ecole Nationale d’Admistration.
Koos Timmermans (1960)
Koos Timmermans was appointed as a member of FMO's Supervisory Board in 2017. He has extensive banking experience in various senior leadership roles. He joined ING in 1996 and was a member of the executive team since 2007 when he was appointed as the company’s first chief risk officer on the Executive Board. In 2011 he became vice-chairman of the Management Board Banking. In 2014 he assumed responsibility for the Market Leaders division. He was appointed chief financial officer in 2017. At ING, he was also responsible for the areas of sustainability, international relations and regulatory affairs.
Dugald Agble (1970)
Dugald Agble is an experienced private equity investor, who has built a solid track record across various top PE firms in London, including Terra Firma Capital Partners and Helios Investment Partners, increasingly focussing on sub Saharan African transactions. Dr. Agble has demonstrated a clear aspiration and dedication to impact investment in diverse industries, including agriculture, manufacturing and health care.
Marjolein Demmers (1967)
Marjolein Demmers is an international thought leader on a broad range of sustainability topics. Since 2017, Mrs. Demmers is Director/Chair of Natuur & Milieu (Nature & Environment), a Dutch environmental NGO with focus on climate change and biodiversity. Before that, she worked at McKinsey & Company, was COO of the renewable energy business of Essent, and she served as Group Compliance Officer and Director Corporate Responsibility at Royal HaskoningDHV.
Reintje van Haeringen (1963)
Reintje van Haeringen is a development expert and manager with experience in Africa, Latin America and Asia. Mrs. Van Haeringen is currently CEO of the NGO Care Nederland. CARE Nederland is a member of the CARE International Confederation, which is dedicated to poverty reduction and social justice worldwide. Before her career at CARE, she was Regional Director, SNV Latin America, amongst other roles. Mrs. Van Haeringen had led various programs in Ecuador, Nicaragua and Honduras.
Eme Essien Lore (1970)
Eme joined the Supervisory Board in 2024 and is a seasoned development finance professional with over 24 years of experience. Her professional career includes management roles at organizations such as the International Finance Corporation (IFC)/World Bank Group and the Rockefeller Foundation. Next to a high level of financial and economic expertise, specifically related to risk matters in emerging markets and economies, Eme specializes in impact investing, corporate governance, and organizational health, with specific attention to diversity & inclusion.
